Royal Marsden NHS Foundation Trust
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
LATe TreatmENT Related Toxicity in Melanoma (LATENT)
Not yet recruiting
- Conditions
- First Posted Date
- 2024-05-16
- Last Posted Date
- 2024-06-25
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 400
- Registration Number
- NCT06414343
- Locations
- 🇬🇧
Royal Marsden NHS Foundation Trust, Chelsea, London, United Kingdom
The Man Van Project
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-04-10
- Last Posted Date
- 2024-05-01
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 4000
- Registration Number
- NCT06357416
- Locations
- 🇬🇧
Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom
Mapping Arterial Perforators Within the Breast During Mammoplasty
Completed
- Conditions
- First Posted Date
- 2024-04-04
- Last Posted Date
- 2024-04-04
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 80
- Registration Number
- NCT06347952
- Locations
- 🇬🇧
Royal Marsden - Surrey, Sutton, England, United Kingdom
The Role of tHyroid cAncer Specific Patient Concerns iNventory (PCI-TC) in Enhancing Shared decisiOn Making
- First Posted Date
- 2024-03-20
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 32
- Registration Number
- NCT06322160
- Locations
- 🇬🇧
Guys & St Thomas, London, United Kingdom
🇬🇧UCLH, London, United Kingdom
Peri-operative Zimberelimab (Anti-PD-1) vs Zimberelimab in Combination With Domvanalimab (Anti-TIGIT) in Resectable Mismatch Repair Deficient/Micro-satellite Unstable Gastric and Gastro-oesophageal Junctional Adenocarcinoma (ZODIAC)
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-02-08
- Last Posted Date
- 2024-02-08
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 50
- Registration Number
- NCT06250036
Inherited Cancer Early Diagnosis (ICED) Study
- First Posted Date
- 2023-12-08
- Last Posted Date
- 2023-12-08
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 100
- Registration Number
- NCT06163365
- Locations
- 🇬🇧
The Royal Marsden NHS Foundation Trust, London, United Kingdom
Gene Expression Profiling in a Validation Cohort of Locally Advanced and Recurrent/Metastatic Salivary Gland Cancers
- First Posted Date
- 2023-10-19
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 250
- Registration Number
- NCT06091878
IMaC - Immune Pathways in Oesophagogastric Cancer
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-09-28
- Last Posted Date
- 2023-10-05
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 310
- Registration Number
- NCT06057220
- Locations
- 🇬🇧
Royal Surrey County Hospital, Guildford, United Kingdom
🇬🇧The Royal Marsden NHS Foundation Trust, London, United Kingdom
🇬🇧St Georges University Hospital, London, United Kingdom
Oncotype DX DCIS: Impact on Radiotherapy Decision Making
Not Applicable
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-09-21
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 78
- Registration Number
- NCT06046664
- Locations
- 🇬🇧
The Royal Marsden NHS Foundation Trust, London, United Kingdom
Sepsis in Oncology Patients
- First Posted Date
- 2023-09-21
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 180
- Registration Number
- NCT06046677
- Locations
- 🇬🇧
The Royal Marsden NHS Foundation Trust, London, United Kingdom
© Copyright 2024. All Rights Reserved by MedPath